Gleason JL - Search Results

1

Dual-function antiandrogen/HDACi hybrids based on enzalutamide and entinostat.

Barrett RRG, Nash C, Diennet M, Cotnoir-White D, Doyle C, Mader S, Thomson AA, Gleason JL. Barrett RRG, et al. Among authors: gleason jl. Bioorg Med Chem Lett. 2022 Jan 1;55:128441. doi: 10.1016/j.bmcl.2021.128441. Epub 2021 Nov 9. Bioorg Med Chem Lett. 2022. PMID: 34767912

2

Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids.

Lamblin M, Dabbas B, Spingarn R, Mendoza-Sanchez R, Wang TT, An BS, Huang DC, Kremer R, White JH, Gleason JL. Lamblin M, et al. Among authors: gleason jl. Bioorg Med Chem. 2010 Jun 1;18(11):4119-37. doi: 10.1016/j.bmc.2010.03.078. Epub 2010 Apr 7. Bioorg Med Chem. 2010. PMID: 20452225

3

An o-aminoanilide analogue of 1α,25-dihydroxyvitamin D(3) functions as a strong vitamin D receptor antagonist.

Lamblin M, Spingarn R, Wang TT, Burger MC, Dabbas B, Moitessier N, White JH, Gleason JL. Lamblin M, et al. Among authors: gleason jl. J Med Chem. 2010 Oct 28;53(20):7461-5. doi: 10.1021/jm1007159. J Med Chem. 2010. PMID: 20883026

4

Role of SUMOylation in full antiestrogenicity.

Hilmi K, Hussein N, Mendoza-Sanchez R, El-Ezzy M, Ismail H, Durette C, Bail M, Rozendaal MJ, Bouvier M, Thibault P, Gleason JL, Mader S. Hilmi K, et al. Among authors: gleason jl. Mol Cell Biol. 2012 Oct;32(19):3823-37. doi: 10.1128/MCB.00290-12. Epub 2012 Jul 23. Mol Cell Biol. 2012. PMID: 22826433 Free PMC article.

5

Synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition.

Fischer J, Wang TT, Kaldre D, Rochel N, Moras D, White JH, Gleason JL. Fischer J, et al. Among authors: gleason jl. Chem Biol. 2012 Aug 24;19(8):963-71. doi: 10.1016/j.chembiol.2012.05.024. Chem Biol. 2012. PMID: 22921063

6

Optimization of histone deacetylase inhibitor activity in non-secosteroidal vitamin D-receptor agonist hybrids.

Kaldre D, Wang TT, Fischer J, White JH, Gleason JL. Kaldre D, et al. Among authors: gleason jl. Bioorg Med Chem. 2015 Aug 1;23(15):5035-5049. doi: 10.1016/j.bmc.2015.05.011. Epub 2015 May 14. Bioorg Med Chem. 2015. PMID: 26048026

7

Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids.

Mendoza-Sanchez R, Cotnoir-White D, Kulpa J, Jutras I, Pottel J, Moitessier N, Mader S, Gleason JL. Mendoza-Sanchez R, et al. Among authors: gleason jl. Bioorg Med Chem. 2015 Dec 15;23(24):7597-606. doi: 10.1016/j.bmc.2015.11.005. Epub 2015 Nov 10. Bioorg Med Chem. 2015. PMID: 26613635

8

Antiestrogens: structure-activity relationships and use in breast cancer treatment.

Traboulsi T, El Ezzy M, Gleason JL, Mader S. Traboulsi T, et al. Among authors: gleason jl. J Mol Endocrinol. 2017 Jan;58(1):R15-R31. doi: 10.1530/JME-16-0024. Epub 2016 Oct 11. J Mol Endocrinol. 2017. PMID: 27729460 Free PMC article. Review.

9

Incorporation of histone deacetylase inhibitory activity into the core of tamoxifen - A new hybrid design paradigm.

Palermo AF, Diennet M, El Ezzy M, Williams BM, Cotnoir-White D, Mader S, Gleason JL. Palermo AF, et al. Among authors: gleason jl. Bioorg Med Chem. 2018 Aug 15;26(15):4428-4440. doi: 10.1016/j.bmc.2018.07.026. Epub 2018 Jul 17. Bioorg Med Chem. 2018. PMID: 30078609

10

An Organocatalytic Oxy-Cope/Michael Cascade Reaction.

Barrett RRG, Campbell DA, Gleason JL. Barrett RRG, et al. Among authors: gleason jl. Org Lett. 2023 Feb 10;25(5):777-781. doi: 10.1021/acs.orglett.2c04269. Epub 2023 Jan 26. Org Lett. 2023. PMID: 36701675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page